Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
about
Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammationLive imaging and gene expression analysis in zebrafish identifies a link between neutrophils and epithelial to mesenchymal transitionThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentRAS oncogenes: weaving a tumorigenic webCXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.Targeting pathways downstream of KRAS in lung adenocarcinoma.Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.Identification of a small molecule inhibitor of serine 276 phosphorylation of the p65 subunit of NF-kappaB using in silico molecular docking.Pancreatic cancer, inflammation, and microbiome.Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance)The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.The association between expressions of Ras and CD68 in the angiogenesis of breast cancers.Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines.Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblastsIL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasiaCarboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid.Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesisHall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms.How the genetics of lung cancer may overlap with COPD.Interleukin-8 (CXCL8) in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values. A review.Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.MAP Kinases and Prostate Cancer.CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.Triggering Ras signalling by intracellular Francisella tularensis through recruitment of PKCα and βI to the SOS2/GrB2 complex is essential for bacterial proliferation in the cytosol.PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reactionRB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells.Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.Tumor Acidosis and Hypoxia Differently Modulate the Inflammatory Program: Measurements In Vitro and In Vivo.Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.Covalent Guanosine Mimetic Inhibitors of G12C KRAS.Targeting cytokine networks in KRAS-driven tumorigenesis.miR-526a regulates apoptotic cell growth in human carcinoma cells.KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation
P2860
Q27322639-F6142832-B286-482C-8F6C-E2DAD8F35764Q27330504-E3B7363F-F860-4C6F-81B0-2C08276AFE74Q28241308-B3263909-A06B-4962-96FF-029C8A964CCEQ28250360-92611D9C-1A14-48D3-A672-3BF7C5770F90Q30358993-45409210-3858-4DF9-AB23-CF51E7F3A782Q30597330-A36F72C7-F18C-4D16-8E10-18CA37F77455Q33756818-1F91E580-3F4A-4785-B451-FAD59881F8D4Q33771143-D420BA23-04E2-44D3-835B-ECF1D932F8BAQ33956107-B64B2732-671D-4096-A138-BE5E864A1EFCQ34447921-560B9C78-6DCE-49E4-B7C0-8011ADC133B4Q34496096-F73F25D3-AC55-4999-8559-73370FDBED61Q35008198-A12FC163-6D14-4D5D-92DB-A532578A0786Q35079068-34A1BB0E-DF95-4181-B17D-6B8F3FDE544CQ35109213-B9660D66-DFDE-4790-9759-A7611C71AFB5Q35376317-6B07F109-B0C8-41A5-A0DB-BFB6DD2BF1BBQ35770438-B5294C78-C9CF-48ED-B9B7-49C15D474C5FQ35916583-C5198834-1003-4FA7-875A-82894ABEF6BBQ37040899-95613822-0F7B-4030-ACD7-3BBDF57AC827Q37403369-A3FEB80A-917F-4141-BEDD-67C3FDAF2F3FQ37406706-CF9B1398-71FD-494B-89B0-515E1C66F2AEQ37437224-3B1895FA-0C8A-4DF6-85C9-ECAFF90E36F0Q37512224-2BBB9CEF-167B-4C84-80E1-37BEDF06BB0AQ37900349-225DDFCB-5F9E-4849-B128-987B5E65713CQ38011647-258A445C-657D-4191-A317-9419FEF8CDA5Q38107793-FE6AFB79-90D4-4750-88BE-C03D4A78332BQ38166232-37035603-BFF7-47F1-87D0-5E6AD3E4ABC9Q38177161-D1D3C6DA-7E29-4E66-95DB-986B093AD40EQ38791344-1EBE2CEE-F3D4-4D30-BCAD-8E0519C01B74Q39459026-D3F9C71D-CFD9-457D-BA7B-4A20B6A4FF73Q39682306-C6BC1498-0F21-49E4-B20E-8D118F9765BCQ41354166-A99A771A-494A-41E9-AFD7-0EDCC2809E83Q41434923-F5D272C9-0DAF-4AF5-8FB8-C288103DBC78Q46758501-A2F119B1-E7DE-4DD1-85D9-3F1DCCEC24ECQ47132574-180CDE8E-32C4-4C42-ACFC-DEC3D0D9D22AQ48056910-CFC8D990-196B-43C2-8242-22AF8E82782FQ51180158-EF4E89D5-6A7F-461B-91E0-3B175A1082F7Q52651080-1050B3D0-CC57-4F17-9F79-FC0F3532B21FQ52941418-F6081CEC-CA95-4B98-8C37-CE6979E4DEE0Q57463782-BC057AB1-E800-4DFB-AED3-1E21840A7A63
P2860
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@en
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@nl
type
label
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@en
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@nl
prefLabel
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@en
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@nl
P2093
P2860
P356
P1476
Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics.
@en
P2093
Brooke B Ancrile
Christopher M Counter
Kevin M O'Hayer
P2860
P356
10.1124/MI.8.1.6
P577
2008-02-01T00:00:00Z